scispace - formally typeset
A

Amanda Jain

Researcher at Brown University

Publications -  5
Citations -  1348

Amanda Jain is an academic researcher from Brown University. The author has contributed to research in topics: National Lung Screening Trial & Lung cancer. The author has an hindex of 4, co-authored 5 publications receiving 1156 citations.

Papers
More filters
Journal ArticleDOI

Results of Initial Low-Dose Computed Tomographic Screening for Lung Cancer

TL;DR: The NLST initial screening results are consistent with the existing literature on screening by means of low-dose CT and chest radiography, suggesting that a reduction in mortality from lung cancer is achievable at U.S. screening centers that have staff experienced in chest CT.
Journal ArticleDOI

Results of the Two Incidence Screenings in the National Lung Screening Trial

TL;DR: Low-dose CT was more sensitive in detecting early-stage lung cancers, but its measured positive predictive value was lower than that of radiography, and the two annual incidence screenings with low- dose CT resulted in a decrease in the number of advanced-stage cancers diagnosed and an increase in thenumber of early-Stage lung cancers diagnosed.
Journal ArticleDOI

Examining whether lung screening changes risk perceptions: National Lung Screening Trial participants at 1‐year follow‐up

TL;DR: Reduced lung cancer mortality among current and former smokers with a minimum 30 pack‐year history who were screened with spiral computed tomography scans compared with chest x‐rays is reported.
Journal ArticleDOI

Identifying and collecting pertinent medical records for centralized abstraction in a multi-center randomized clinical trial: The model used by the American College of Radiology arm of the National Lung Screening Trial

TL;DR: The process to develop a HIPAA-compliant centralized process to collect medical record information for a large multi-center cancer screening trial satisfied requirements imposed by the Health Insurance Portability and Accountability Act and concerns of site institutional review boards with respect to protected health information.